Boc-Asp(OMe)-fluoromethyl ketone No Further a Mystery
Participant has experienced any other prior or concurrent malignancy inside two decades before enrollment with the next exceptions: sufficiently treated localized basal cell or squamous mobile carcinoma, or curatively addressed in situ carcinoma of the cervix or breast. Other exceptions could possibly be considered upon sponsor consultation.In dose